Alamar Biosciences Inc (ALMR) 財務データ
*すべての数値は百万単位です
| 期間終了日 | 2026-09-30 | 2026-06-30 | 2026-03-31 |
|---|---|---|---|
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 |
| Revenues | 13.99%33.55 | 29.43 | 26.04 |
| Cost Of Revenue | 10.18%12.90 | 11.71 | 11.58 |
| Gross Profit | 16.51%20.64 | 17.72 | 14.46 |
14.51%35.78 | 31.25 | 26.80 | |
| Selling, General, and Administrative | 12.52%19.62 | 17.43 | 13.79 |
| Research and Development | 17.01%16.17 | 13.82 | 13.02 |
| Depreciation and Amortization | 25.57%1.42 | 1.13 | 1.17 |
| Operating Income/Loss | 11.88%-15.14 | -13.53 | -12.35 |
| Income/Loss From Continuing Operations Before Tax | 0.33%-13.25 | -13.29 | -20.86 |
| Income Tax Expense/Benefit | 201.08%0.09 | -0.09 | 0.46 |
1.08%-13.34 | -13.20 | -21.33 | |
| Attributable To Parent | 1.08%-13.34 | -13.20 | -21.33 |
| Basic Average Shares | 17.80%69.11 | 58.67 | 12.26 |
| Diluted Average Shares | 17.80%69.11 | 58.67 | 12.26 |
| Basic Earnings Per Share | 13.64%-0.19 | -0.22 | -1.74 |
| Diluted Earnings Per Share | 13.64%-0.19 | -0.22 | -1.74 |